首页> 美国卫生研究院文献>Rheumatology and Therapy >Use of Anti-Tumor Necrosis Factor Therapy: A Retrospective Study of Monotherapy and Adherence to Combination Therapy with Non-Biologic Disease-Modifying Anti-Rheumatic Drugs

【2h】

Use of Anti-Tumor Necrosis Factor Therapy: A Retrospective Study of Monotherapy and Adherence to Combination Therapy with Non-Biologic Disease-Modifying Anti-Rheumatic Drugs

机译：抗肿瘤坏死因子疗法的应用：回顾性研究单一疗法和坚持与非生物疾病修改抗风湿药的联合疗法。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

IntroductionThis study examined the use of anti-tumor necrosis factor (anti-TNF) monotherapy, adherence with non-biologic disease-modifying anti-rheumatic drugs (nbDMARDs) in patients receiving a combination of anti-TNF therapies and nbDMARDs, and the impact of nbDMARD adherence on anti-TNF persistence among patients with rheumatoid arthritis (RA).

机译：简介这项研究检查了抗肿瘤坏死因子（anti-TNF）单一疗法的使用，对非生物疾病改良抗风湿药（nbDMARDs）的依从性以及接受TNF疗法和nbDMARDs联合治疗的患者的影响nbDMARD对类风湿关节炎（RA）患者抗TNF持久性的依从性。

著录项

期刊名称 Rheumatology and Therapy
作者
Nicole M. Engel-Nitz; Sarika Ogale; Mahesh Kulakodlu;
展开▼
作者单位

展开▼
年(卷),期 2015(2),2
年度 2015
页码 127–139
总页数 13
原文格式 PDF
正文语种
中图分类免疫性疾病;
关键词
Adherence Anti-TNF therapy Combination therapy Discontinuation DMARD Persistence Rheumatoid arthritis;

机译：依从性;抗TNF治疗;联合治疗;停药;DMARD;持续性;类风湿关节炎;

相似文献

外文文献
中文文献
专利

1. Use of Anti-Tumor Necrosis Factor Therapy: A Retrospective Study of Monotherapy and Adherence to Combination Therapy with Non-Biologic Disease-Modifying Anti-Rheumatic Drugs [J] . Nicole M. Engel-Nitz, Sarika Ogale, Mahesh Kulakodlu Rheumatology and Therapy . 2015,第2期

机译：抗肿瘤坏死因子疗法的应用：回顾性研究单一疗法和坚持与非生物疾病修改抗风湿药的联合疗法。
2. Use of Anti-Tumor Necrosis Factor Therapy: A Retrospective Study of Monotherapy and Adherence to Combination Therapy with Non-Biologic Disease-Modifying Anti-Rheumatic Drugs [J] . Nicole M. Engel-Nitz, Sarika Ogale, Mahesh Kulakodlu Rheumatology and Therapy . 2015,第2期

机译：抗肿瘤坏死因子疗法的应用：回顾性研究单一疗法和坚持与非生物疾病修改抗风湿药的联合疗法。
3. Intestinal microsporidiosis: a hidden risk in rheumatic disease patients undergoing anti-tumor necrosis factor therapy combined with disease-modifying anti-rheumatic drugs? [J] . Aline De Oliveira Twardowsky, Ana Cristina De Medeiros Ribeiro, Carla Goncalves Schain Saad, Clinics . 2011,第7期

机译：肠道微孢子虫病：风湿病患者接受抗肿瘤坏死因子疗法联合疾病改良抗风湿药的隐患？
4. Radium-223 Dichloride Monotherapy and Combination Therapy with Zoledronic Acid or Doxorubicin Improve Survival in a Mouse Model of Breast Cancer Bone Metastasis [C] . Jukka Rissanen, Mari Suominen, Rami K?k?nen, Molecular Medicine TRI-CON. . 2014

机译：镭-223二氯化物单疗法和组合治疗唑醇或多柔比星改善了乳腺癌骨转移的小鼠模型中的存活
5. The evaluation of anti-cancer effects of FL118 in retinoblastoma in monotherapy and combination therapies. [D] . Singh, Jasman Kaur. 2014

机译：在单一疗法和联合疗法中评估FL118在视网膜母细胞瘤中的抗癌作用。
6. Intestinal microsporidiosis: a hidden risk in rheumatic disease patients undergoing anti-tumor necrosis factor therapy combined with disease-modifying anti-rheumatic drugs? [O] . Nadia Emi Aikawa, Aline de Oliveira Twardowsky, Jozélio Freire de Carvalho, 2011

机译：肠道微孢子虫病：风湿病患者接受抗肿瘤坏死因子疗法联合疾病改良抗风湿药的隐患？
7. Use of Anti-Tumor Necrosis Factor Therapy: A Retrospective Study of Monotherapy and Adherence to Combination Therapy with Non-Biologic Disease-Modifying Anti-Rheumatic Drugs [O] . 2015

机译：抗肿瘤坏死因子疗法的应用：回顾性研究单一疗法和坚持与非生物疾病修改抗风湿药的联合疗法。

Use of Anti-Tumor Necrosis Factor Therapy: A Retrospective Study of Monotherapy and Adherence to Combination Therapy with Non-Biologic Disease-Modifying Anti-Rheumatic Drugs

摘要

著录项

相似文献

相关主题

期刊订阅